Navigation Links
Single drug for bipolar disorder,,

Researchers have pointed out that on a short term a single drug may be used to treat both the phases of bipolar disorder //.

Bipolar disorder is a psychotic disorder characterized by successive feelings of elation and depression. Also known as manic-depressive illness that affects 3 to 4 5 of the global adult population. This is a chronic condition and most of the sufferers have multiple occurrences of the condition for most of their lives.

Researchers from University Hospitals of Cleveland and others have reported that antipsychotic medications are effective in the short term for treating both the manic as well as the depressive phases of the bipolar disorder. Currently antipsychotic drugs like Seroquel are used in treating the manic phase of the bipolar disorder and schizophrenia. With the new research report the researchers say that it is possible to treat bipolar disorder with only a single drug for all its phases.

In the study done for the drug Seroquel, patients of the bipolar disease taking the drug reported about 50% more improvement in their quality of life than their counterparts who had taken the placebo.

Reference: American Journal of Psychiatry, July 2005
'"/>




Page: 1

Related medicine news :

1. Single gene analysis for diagnosis of a range of blood disorders
2. Treating Testicular Cancer With A Single Dose Of Chemotherapy
3. Decreasing Multiple Births By Single Embryo Transfers
4. Single gene skin cancer cause
5. Drug Firms To Produce Single Pill AIDS Treatment
6. Malaria May Gain Resistance To Single Drug Prescriptions
7. Single Women with Baby Cravings Can Actually Cradle their Own, Courtesy NHS
8. Thai Doctors Removed 421 Kidney Stones From A Single Person
9. Single Dose Of Azithromycin Could Cure Trichiasis
10. Effects Of Certain Food Related To Single Pain Receptors
11. Single Dose Of Extended Release Metformin Found To Be Effective In Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® ... area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony ... Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ...
(Date:12/4/2016)... Washington DC (PRWEB) , ... December 04, 2016 , ... ... Environmental, one of the most certified and experienced Indoor Air Quality Companies in VA, ... Assessment and Remediation Regulations. , The new mold law in the district ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: